Variations in glucose/C-peptide ratio in patients with type 2 diabetes associated with renal function

This publication has 32 references indexed in Scilit:

• The clinical utility of C‐peptide measurement in the care of patients with diabetes
  Diabetic Medicine, 2013
• Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin
  BMC Endocrine Disorders, 2012
• Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients
  Diabetes & Metabolism Journal, 2012
• Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of “A-β+” ketosis-prone diabetes based on long-term β-cell function, human leukocyte antigen class II alleles, and sex predilection
  Metabolism, 2010
• Effects of Intensive Glucose Lowering in Type 2 Diabetes
  New England Journal of Medicine, 2008
• Glucose and Insulin Metabolism in Uremia
  Nephron, 1992
• Elimination of Requirement for Exogenous Insulin Therapy in Diabetic Renal Failure
  Clinical and Experimental Dialysis and Apheresis, 1982
• Myocardial dysfunction without coronary artery disease in diabetic renal failure
  The American Journal of Cardiology, 1979
• Evidence for Cardiomyopathy in Familial Diabetes Mellitus
  Journal of Clinical Investigation, 1977
• New type of cardiomyopathy associated with diabetic glomerulosclerosis
  The American Journal of Cardiology, 1972